UBS O'Connor »

Rapt Therapeutics shares owned by UBS O'Connor

Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by UBS O'Connor from 13F filings

Historical chart of UBS O'Connor investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by UBS O'Connor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by UBS O'Connor

Quarter filed Position value Share count Share price at filing
2024-03-31 $248k 98k 2.53
2023-09-30 $1.6M 94k 16.62
2023-06-30 $1.8M 97k 18.70
2023-03-31 $1.7M 92k 18.35
2022-12-31 $1.7M 88k 19.80
2022-09-30 $1.7M 70k 24.06
2022-06-30 $1.4M 79k 18.25
2020-03-31 $213k 10k 21.30